Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid, Instrumentation Laboratories to Develop Hemostasis Dxs; IL to Market Them

NEW YORK (GenomeWeb News) — Cepheid and Instrumentation Laboratory intend to develop and distribute diagnostics for hemostasis applications, Cepheid said today.  
  
Under the agreement, Cepheid will develop tests to be used on its GeneXpert technology, while IL will market them as part of its panel of hemostasis diagnostic assays.
  
Cepheid said it first plans to develop the Xpert HemosIL tests to detect Factor II and Factor V mutations, which are genetic variations associated with thrombosis.
  
Financial terms of the agreement were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.